tiprankstipranks

Dennis Mulroy Insider Profile

4 Followers
Dennis Mulroy, CFO at La Jolla Pharma, holds 964.00 shares in AnaptysBio (Ticker: ANAB), holds 5.07K shares in La Jolla Pharma (Ticker: LJPC), holds ― shares in Taxus Cardium Pharmaceuticals Group (Ticker: CRXM).
tipranks
Dennis Mulroy

Dennis Mulroy
La Jolla Pharma (LJPC)
CFO

Ranked #55,814 out of 98,624 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-6.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$20K
100.00%
0.00%
A breakdown of Dennis Mulroy's holdings

Insider Roles

AnaptysBio
(ANAB)
CFO
Taxus Cardium Pharmaceuticals Group
(CRXM)
Chief Financial Officer
Roles that Dennis Mulroy holds in companies

Most Profitable Insider Trade

Stock:
La Jolla Pharma
(LJPC)
Rating:Informative Buy
Date:Mar 06, 2017 - Mar 06, 2018
Return:-4.40%
The most profitable trade made by Dennis Mulroy

Dennis Mulroy's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
LJPC
La Jolla Pharma
Jun 02, 2020
Uninformative Buy
328.82
$31.52K
AnaptysBio
Feb 01, 2024
CFO
Uninformative Sell
72.40K
$20.24K
Taxus Cardium Pharmaceuticals Group
Chief Financial Officer
List of latest transactions for each holding click on a transaction to see Dennis Mulroy's performance on stock

Dennis Mulroy insider profile FAQ

What is the percentage of profitable transactions made by Dennis Mulroy?
The percentage of profitable transactions made by Dennis Mulroy is 0%.
    What is the average return per transaction made by Dennis Mulroy?
    The average return per transaction made by Dennis Mulroy is -6.60%.
      What stocks does Dennis Mulroy hold?
      Dennis Mulroy holds: LJPC, ANAB, CRXM stocks.
        What was Dennis Mulroy’s latest transaction?
        Dennis Mulroy latest transaction was an Uninformative Sell of $72.40K.
          What was Dennis Mulroy's most profitable transaction?
          Dennis Mulroy’s most profitable transaction was an Informative Buy of LJPC stock on March 6, 2017. The return on the trade was -4.40%.
            What is Dennis Mulroy's role in La Jolla Pharma?
            Dennis Mulroy's role in La Jolla Pharma is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.